Current Duke Appointments & Affiliations
Postdoctoral Associate
Pharmacology & Cancer Biology,
Basic Science Departments
Recent Scholarly Works
KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma.
Journal article Cancer Res · June 18, 2026 Lung squamous cell carcinoma (LUSC) is a basal-like subtype of lung cancer with limited treatment options. While prior studies have identified tumor-propagating cell states in squamous tumors, further work is needed to elucidate the broader landscape of in ... Full text Link to item CiteTMPRSS11B promotes an acidified microenvironment and immune suppression in squamous lung cancer.
Journal article EMBO Rep · December 2025 Lung cancer is the leading cause of cancer-related deaths worldwide. Existing therapeutic options have limited efficacy, particularly for lung squamous cell carcinoma (LUSC), underscoring the critical need for the identification of new therapeutic targets. ... Full text Link to item CiteTransmembrane Serine Protease TMPRSS11B promotes an acidified tumor microenvironment and immune suppression in lung squamous cell carcinoma.
Journal article bioRxiv · April 3, 2025 Lung cancer is the leading cause of cancer-related deaths worldwide. Existing therapeutic options have limited efficacy, particularly for lung squamous cell carcinoma (LUSC), underscoring the critical need for the identification of new therapeutic targets. ... Full text Link to item CiteRecent Grants
KLF4 drives resistance to chemotherapy through a hillock-like state in lung squamous cell carcinoma
ResearchPI-Fellow · Awarded by American Cancer Society, Inc. · 2025 - 2028Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
ResearchPostdoctoral Associate · Awarded by National Institutes of Health · 2022 - 2026Pro-tumor functions of neutrophils in squamous cell lung cancer
ResearchPostdoctoral Associate · Awarded by National Institutes of Health · 2022 - 2025View All Grants